• K. A. Halmi
Part of the Psychiatrie der Gegenwart book series (SPEZIELLE, volume 8)


Die beiden wichtigsten Eßstörungen sind Anorexia nervosa und Bulimia nervosa. Umfangreiche Forschungsergebnisse liegen zu diesen Störungen vor, die als Syndrome betrachtet werden sollten, denn sie sind keine nosologischen Entitäten mit übereinstimmender Ursache, identischem Verlauf sowie gemeinsamer Pathologie.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. APA (1994) Diagnostic and Statistical manual of mental disorders (DSM-IV). APA, Washington DCGoogle Scholar
  2. Campbell D, Sundaramurthy D, Markham A. et al. (1997) Lack of association between 5-HT2a gene promoter polymorphism and susceptibility to anorexia nervosa. Lancet 351:499–503CrossRefGoogle Scholar
  3. Casper RC (1990) Personality features of women with good outcome from restricting anorexia nervosa. Psychosom Med 52:156–170PubMedGoogle Scholar
  4. Collier DA, Arranz M, Lee T. et al. (1997) Association between 5-HT2a gene promoter polymorphism and anorexia nervosa. Lancet 350:412–413PubMedCrossRefGoogle Scholar
  5. Connors ME, Morse W (1993) Sexual abuse and eating disorders: a review. Int J Eat Disord 13:1–11PubMedCrossRefGoogle Scholar
  6. Crago M, Schisslak CM, Estes LS (1996) Eating disturbances among American minority groups: a review. Int J Eat Disord 19:239–248PubMedCrossRefGoogle Scholar
  7. Crisp AH (1984) Premorbid factors in adult disorders of weight, with particular reference to primary anorexia nervosa (weight phobia). J Psychosom Res 14:1–22CrossRefGoogle Scholar
  8. Devlin MJ, Walsh BT, Kralg D. et al. (1990) Metabolie abnormalities in bulimia nervosa. Arch Gen Psychiatry 47:144–148PubMedCrossRefGoogle Scholar
  9. Eckert ED, Halmi KA, Marchi EP. et al. (1995) Ten year follow up of anorexia nervosa: clinical course and outcome. Psychol Med 25:143–156PubMedCrossRefGoogle Scholar
  10. Eckert E, Pomeroy C, Raymond N. et al. (1998) Leptin in anorexia nervosa. J Clin Endocrinol Metab 83 791–7 95PubMedCrossRefGoogle Scholar
  11. Enoch M, Kaye W, Rotondo A. et al. (1998) 5-HT2a promoter polymorphism-1438 G/A, anorexia nervosa, and obsessive compulsive disorder. Lancet 351:1785–1786PubMedCrossRefGoogle Scholar
  12. Fairburn CG, Beglin SJ (1990) Studies of the epidemiology of bulimia nervosa. Am J Psychiatry 147:401–408PubMedGoogle Scholar
  13. Fairburn CG, Cooper PJ (1984) The clinical features of bulimia nervosa. Br J Psychiatry 144:238–246PubMedCrossRefGoogle Scholar
  14. Fairburn CG, Wilson JT (1993) Cognitive-behavioral therapy for binge eating and bulimia nervosa: a comprehensive treatment manual. In: Fairburn CG, Wilson JT (eds) Binge eating: nature, assessment and treatment. Guilford, New York, pp 361–404Google Scholar
  15. First M, Spitzer R, Gibbon M. et al. (1995) The struetured clinical interview for DSM-IV axis I disorders and personality disorders. Psychiatric Institute, New YorkGoogle Scholar
  16. Frisch S (1985) Fatness, menarche and female fertility. Persp Biol Med 28:611–633Google Scholar
  17. Gardner DM, Bemis KM (1982) A cognitive-behavioral approach to anorexia nervosa. Cogn Ther Res 6:1223–1250Google Scholar
  18. Halmi KA (1984) Behavioral management of anorexia nervosa. In: Garner D, Garfinkel P (eds) Treatment of anorexia nervosa and bulimia. Guilford, New York, pp 147–160Google Scholar
  19. Halmi KA (1994) Eating disorders. In: Haies KE, Uydofsky SC, Talbott J (eds) Textbook of psychiatry, 2nd edn. American Psychiatric Press, Washington DC, pp 857–875Google Scholar
  20. Halmi KA (1995) Basic biological overview of eating disorders. In: Bloom FE, Kupfor DJ (eds) Psychopharmacology; the fourth generation of progress. Raven, New York, pp 1609–1616Google Scholar
  21. Halmi KA, Eckerts E, Ladut. et al. (1986) Anorexia nervosa: treatment efficacy of cyproheptadine and amitriptyline. Arch Gen Psychiatry 43:177–181PubMedCrossRefGoogle Scholar
  22. Halmi KA, Eckert E, Marchi EP. et al. (1991) Comorbidity of Psychiatric diagnoses in anorexia nervosa. Arch Gen Psychiatry 48:712–718PubMedCrossRefGoogle Scholar
  23. Hinney A, Ziegler A, Nöthen M. et al. (1997) 5-HT2a reeeptor gene polymorphisms, anorexia nervosa and obesity. Lancet 351:1324–1325CrossRefGoogle Scholar
  24. Hoek HW (1991) The incidence and prevalence of anorexia nervosa and bulimia nervosa in primary care. Psychol Med 21:455–460PubMedCrossRefGoogle Scholar
  25. Hoek HW (1993) Review of the epidemiological studies of eating disorders. Int Rev Psychiatry 5:61–74CrossRefGoogle Scholar
  26. Hsu H, Crisp A (1979) Outcome of anorexia nervosa. Lancet 1:61–65PubMedCrossRefGoogle Scholar
  27. Jimerson DC, Wolfe BE, Metzger ED. et al. (1997) Decreased Serotonin funetion in bulimia nervosa. Arch Gen Psychiatry 54:529–534PubMedCrossRefGoogle Scholar
  28. Kaye WH, George DT, Gwirtsman H. et al. (1991) Altered Serotonin activity in anorexia nervosa after long-term weight restoration. Arch Gen Psychiatry 48:556–562PubMedCrossRefGoogle Scholar
  29. Keel P, Mitchell JE (1997) Outcome in bulimia nervosa. Am J Psychiatry 154:313–321PubMedGoogle Scholar
  30. Kendler KS, MacLean C, Neal M. et al. (1991) The genetic epidemiology of bulimia nervosa. Am J Psychiatry 148:1627–1637PubMedGoogle Scholar
  31. Kleifield EI, Wagner S, Halmi KA (1996) Cognitive-behavioral treatment of anorexia nervosa. Psychiatr Clin North Am 19:715–737PubMedCrossRefGoogle Scholar
  32. Lee S, Ho TP, Hsu LKG (1993) Fat phobic and non fat phobic anorexia nervosa: a comparative study of 70 Chinese patients in Hong Kong. Psychol Med 23:999–1017PubMedCrossRefGoogle Scholar
  33. Lee S, Leung T, Lee AM. et al. (1996) Body dissatisfaction among Chinese undergraduates and its implications for eating disorders in Hong Kong. Int J Eat Disord 20:77–84PubMedCrossRefGoogle Scholar
  34. Levitan RD, Kaplan AS, Joffe RT (1997) Hormonal and subjective responses to intravenous metachlorophenyl piperazine in bulimia nervosa. Arch Gen Psychiatry 54:521–587PubMedCrossRefGoogle Scholar
  35. Mazure CM, Halmi KA, Sunday SR. et al. (1994) Yale-Brown-Cornell Eating Disorder Scale: development, use, reliability and validity. J Psychiatr Res 28:425–445PubMedCrossRefGoogle Scholar
  36. Mitchell JE, Raymond NC (1992) Cognitive-behavioral therapy and the treatment of bulimia nervosa. In: Halmi KA (ed) The psychobiology and treatment of anorexia nervosa and bulimia nervosa. American Psychiatric Press, Washington DCGoogle Scholar
  37. Mitchell JE, deZwaan M (1993) Pharmacological treatments of binge eating. In: Fairburn CG, Wilson JT (eds) Binge eating: nature, assessment and treatment. Guilford, New YorkGoogle Scholar
  38. Rosenberg M (1979) Conceiving the seif. Basic, New YorkGoogle Scholar
  39. Russell GFM, Szmuckler GL, Dare C. et al. (1987) An evaluation of family therapy in anorexia nervosa and bulimia nervosa. Arch Gen Psychiatry 44:1047–1056PubMedCrossRefGoogle Scholar
  40. Sorbi S, Nacmias B, Jedde A(1998) 5-HT2a promoter polymorphism in anorexia nervosa. Lancet 351:1785PubMedCrossRefGoogle Scholar
  41. Strober M (1980) Personality and symptomatological features in young, nonchronic anorexia nervosa patients. J Psychosom Res 24:353–359PubMedCrossRefGoogle Scholar
  42. Strober M, Humphrey LL (1987) Familial contributions to the etiology and course of anorexia and bulimia. J Consult Clin Psychol 55:654–659PubMedCrossRefGoogle Scholar
  43. Strober M, Lampert C, Morrell W. et al. (1990) A controlled family study of anorexia nervosa: evidence of familial aggregation and lack of shared transmission with affective disorders. Int J Eat Disord 9:239–253CrossRefGoogle Scholar
  44. Theander S (1970) Anorexia nervosa: a Psychiatric investigation of 94 female cases. Acta Psychiatr Scand Suppl 214:1–94PubMedGoogle Scholar
  45. Theander S (1985) Outcome and prognosis in anorexia nervosa and bulimia: some results of previous investigations compared with those with a Swedish longterm study. J Psychiatr Res 19:493–504PubMedCrossRefGoogle Scholar
  46. Toner BB, Garfinkel PE, Garner DM (1988) Affective and anxiety disorders in long-term follow-up of anorexia nervosa. Int J Psychiatr Med 18:357–364CrossRefGoogle Scholar
  47. Treasure J, Holland AJ (1989) Genetic vulnerability to eating disorders: evidence from twin and family studies. In: Remschmidt H, Schmidt MH (eds) Child and youth psychiatry: European perspectives. Hogrefe & Huber, New York, pp 59–68Google Scholar
  48. Vandereycken W, Koge L, Vanderlinden J (1989) The family approach to eating disorders: assessment and treatment of anorexia nervosa and bulimia. PMA, New YorkGoogle Scholar
  49. Vitousek K, Manke F (1994) Personality variables and disorders in anorexia nervosa and bulimia nervosa. J Abnorm Psychol 103:137–147PubMedCrossRefGoogle Scholar
  50. Waller G, Halek C, Crisp AH (1993) Sexual abuse as a factor in anorexia nervosa. Evidence from two separate case series. J Psychosom Res 37:873–879Google Scholar
  51. Walsh BT, Devlin MJ (1992) The pharmacological treatment of eating disorders. Psychiatr Clin North Am 3:149–160Google Scholar
  52. Weissman J, Bothwell S (1976) Assessment of social adjustment by patient seif report. Arch Gen Psychiatry 33:1111–1115PubMedCrossRefGoogle Scholar
  53. Wonderlich SA (1995) Personality and eating disorders. In: Brownell NKD, Fairburn CD (eds) Eating disorders and obesity: a comprehensive handbook. Guilford, New York, pp 171–176Google Scholar
  54. Wonderlich SA, Mitchell JE (1992) Eating disorders and personality disorders. In: Yager J, Gwirtsman HE, Edelstein CK (eds) Special problems in managing eating disorders. American Psychiatric Press, Washington DC, pp 51–86Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • K. A. Halmi

There are no affiliations available

Personalised recommendations